Zydus Seeks DCGI Nod to Undertake Clinical Trials for Monoclonal Antibodies Cocktail
Zydus has announced biological therapy ZRC-3308, used to treat mild COVID-19. The pharmaceutical company now seeks DCGI (Drugs Controller General of India) nod to undertake...
